Recommendation ID
NG14/02
Question

Safety, prognostic and predictive biomarkers: Can biomarkers be used for risk stratification and treatment planning for people with melanoma?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale section on BRAF analysis of melanoma tissue samples.

Full details of the evidence and the committee's discussion are in evidence review A: genetic testing for melanoma.


Source guidance details

Comes from guidance
Melanoma: assessment and management
Number
NG14
Date issued
July 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/07/2022